SHINE Technologies

Private

Nuclear fusion company commercializing fusion-based technologies through a phased strategy: industrial testing (FLARE neutron source), medical isotopes (Lu-177 for cancer therapy, Mo-99 for diagnostics), nuclear waste recycling, and ultimately fusion energy. The Cassiopeia facility in Janesville, WI is the largest n.c.a. Lu-177 production facility in North America (200,000 doses/year capacity). Achieved first-ever visible Cherenkov radiation produced by fusion in 2023.

Founders Greg Piefer

CEO Greg Piefer

Company

Headquarters

Janesville, US

Financials

Total Funding

$1.0B

Sectors

Climate Tech Biotech Hardware

www.shinefusion.com Twitter

Funding History

7 rounds

Series E Feb 26, 2026

$240M

NantWorks (Lead) Fidelity Management & Research Sumitomo Corporation of Americas Pelican Energy Partners Deerfield Management Oaktree Capital Management

Series D Oct 11, 2023

$70M

Baillie Gifford (Lead) Fidelity Management & Research (Lead)

Series C Jun 28, 2021

$150M

Koch Disruptive Technologies (Lead) Fidelity Management & Research Baillie Gifford

Series C Sep 2, 2020

$80M

Fidelity Management & Research (Lead)

Debt Oct 7, 2019

$50M

Credit facility (debt, not equity). Not included in total funding.

Oaktree Capital Management (Lender) Deerfield Management

Series B Nov 27, 2018

$30M

Deerfield Management (Lead)

Series A Oct 10, 2014

$125M

Deerfield Management (Lead)

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.